Reviv3 Procare Company
RVIV · OTC
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | 16.9% | 906.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | 73.4% | 75.3% | 64.5% |
| EBITDA | $0 | $0 | $0 | -$0 |
| % Margin | – | 5.5% | 9.1% | -7.2% |
| Net Income | $0 | $0 | $0 | -$0 |
| % Margin | – | 0% | 7.8% | -6.6% |
| EPS Diluted | 0 | 0 | 0.1 | -0.074 |
| % Growth | – | -100% | 235.9% | – |
| Operating Cash Flow | $0 | $0 | $0 | -$0 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | -$0 |